Bone marrow stromal cells drive IL-6 metabolic rewiring and bortezomib resistance in multiple myeloma
Bone marrow stromal cells drive interleukin-6-mediated metabolic reprogramming and bortezomib resistance in multiple myeloma, a new open-access study reports.
